Autolus Therapeutics (AUTL) Treasury Shares (2022 - 2025)

Autolus Therapeutics (AUTL) has 4 years of Treasury Shares data on file, last reported at $16250.0 in Q2 2025.

• For the quarter ending Q2 2025, Treasury Shares fell 61.22% year-over-year to $16250.0; the trailing twelve-month figure through Jun 2025 stood at $16250.0 (down 61.22% YoY), and the FY2024 full-year result was $32412.0, down 72.16% from the prior year.
• Treasury Shares for Q2 2025 stood at $16250.0, roughly flat from $16250.0 in the prior quarter.
• Across five years, Treasury Shares topped out at $403331.0 in Q4 2022 and bottomed at $16250.0 in Q1 2025.
• The 4-year median for Treasury Shares is $39045.5 (2024), against an average of $88561.1.
• The widest annual swing landed in 2024, when Treasury Shares plunged 72.16%; it then sank 61.22% in 2025.
• A 4-year view of Treasury Shares shows it stood at $403331.0 in 2022, then tumbled by 71.13% to $116436.0 in 2023, then slumped by 72.16% to $32412.0 in 2024, then plunged by 49.86% to $16250.0 in 2025.
• The last three Treasury Shares figures came in at $16250.0 (Q2 2025), $16250.0 (Q1 2025), and $32412.0 (Q4 2024), per Business Quant data.

Peer Comparison